Natthaphat Siri-Angkul

Natthaphat Siri-Angkul

Auto-generated profile, based on publicly available information

Natthaphat Siri-Angkul

Department of Medicine, School of Medicine and Public Health, University of Wisconsin - Madison, Madison, WI, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
NSNatthaphat Siri-Angkul
Natthaphat Siri-Angkul
ZSZhen Song
Zhen Song
NFNadezhda Fefelova
Nadezhda Fefelova
JGJudith K. Gwathmey
Judith K. Gwathmey
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn
LXLai-Hua Xie
Lai-Hua Xie
Background: Arrhythmias and heart failure are common cardiac complications leading to substantial morbidity and mortality in patients with hemochromatosis, yet mechanistic insights remain incomplete. We investigated the effects of iron (Fe) on electrophysiological properties and intracellular Ca 2+ (Ca 2+ i ) handling in mouse left ventricular cardiomyocytes. Methods: Cardiomyocytes were isolated from the left ventricle of mouse hearts and were superfused with Fe 3+ /8-hydroxyquinoline complex (5–100 μM). Membrane potential and ionic currents including TRPC (transient receptor potential canonical) were recorded using the patch-clamp technique. Ca 2+ i was evaluated by using Fluo-4. Cell contraction was measured with a video-based edge detection system. The role of TRPCs in the genesis of arrhythmias was also investigated by using a mathematical model of a mouse ventricular myocyte with the incorporation of the TRPC component. Results: We observed prolongation of the action potential duration and induction of early and delayed afterdepolarizations in myocytes superfused with 15 µmol/L Fe 3+ /8-hydroxyquinoline complex. Iron treatment decreased the peak amplitude of the L-type Ca 2+ current and total K + current, altered Ca 2+ i dynamics, and decreased cell contractility. During the final phase of Fe treatment, sustained Ca 2+ i waves and repolarization failure occurred and ventricular cells became unexcitable. Gadolinium abolished Ca 2+ i waves and restored the resting membrane potential to the normal range. The involvement of TRPC activation was confirmed by TRPC channel current recordings in the absence or presence of functional TRPC channel antibodies. Computer modeling captured the same action potential and Ca 2+ i dynamics and provided additional mechanistic insights. Conclusions: We conclude that iron overload induces cardiac dysfunction that is associated with TRPC channel activation and alterations in membrane potential and Ca 2+ i dynamics.

19 May 2024 in Channels
Verified
Journal Article
Open access
NSNatthaphat Siri-Angkul
Natthaphat Siri-Angkul
TKTimothy Kamp
Timothy Kamp
L-type calcium channels (LTCCs), the major portal for Ca2+ entry into cardiomyocytes, are essential for excitation-contraction coupling and thus play a central role in regulating overall cardiac function. LTCC function is finely tuned by multiple signaling pathways and accessory proteins. Leucine-rich repeat-containing protein 10 (LRRC10) is a little studied cardiomyocyte-specific protein recently identified as a modulator of LTCCs. LRRC10 exerts a remarkable effect on LTCC function, more than doubling L-type Ca2+ current (ICa,L) amplitude in a heterologous expression system by altering the gating of the channels without changing their surface membrane expression. Genetic ablation of LRRC10 expression in mouse and zebrafish hearts leads to a significant reduction in ICa,L density and a slowly progressive dilated cardiomyopathy in mice. Rare sequence variants of LRRC10 have been identified in dilated cardiomyopathy and sudden unexplained nocturnal cardiac death syndrome, but these variants have not been clearly linked to disease. Nevertheless, the DCM-associated variant, I195T, converted LRRC10 from a ICa,L potentiator to a ICa,L suppressor, thus illustrating the wide dynamic range of LRRC10-mediated ICa,L regulation. This review focuses on the contemporary knowledge of LTCC modulation by LRRC10 and discusses potential directions for future investigations.

27 December 2023 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
TOThura Tun Oo
Thura Tun Oo
WPWasana Pratchayasakul
Wasana Pratchayasakul
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn
NSNatthapat Siri-Angkul
Natthapat Siri-Angkul
JCJirachaya Choovuthayakorn
Jirachaya Choovuthayakorn
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
WPWasana Pratchayasakul
Wasana Pratchayasakul
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn
NSNatthapat Siri‐Angkul
Natthapat Siri‐Angkul
JCJirachaya Choovuthayakorn
Jirachaya Choovuthayakorn
TCThanapat Charumporn
Thanapat Charumporn
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn
Background: Long‐term high‐fat diet consumption causes prediabetic conditions with brain pathology, as indicated by peripheral and brain insulin resistance, neuroinflammation, neuronal necroptosis, microglial and astrocyte hyperactivation and increased Alzheimer’s disease‐related proteins including amyloid precursor protein (APP). Although pioglitazone, a peroxisome proliferator‐activated receptor (PPAR)‐γ agonist clinically used to treat type 2 diabetes mellitus, has been shown to improve the metabolic and brain functions in prediabetic condition, this drug can lead to several adverse effects. Recently, an in vitro study showed that Cyclosorus terminans extract, which acts as a natural PPAR‐γ agonist, possessed anti‐diabetic and anti‐obesity properties in adipose‐derived stem cells. However, the comparative efficacy of Cyclosorus terminans extract and pioglitazone on metabolic and brain functions in the prediabetic model has not been elucidated.Method: Thirty male rats were fed with either a normal diet (ND) or a high‐fat diet (HFD) for 14 weeks. At week 13, ND‐fed rats received vehicle (NDV; n = 6) for additional 2 weeks. HFD‐fed rats were divided into four subgroups to receive either vehicle (HFV; n = 6), 100 mg/kg/day of Cyclosorus terminans extract (I‐100; n = 6), 200 mg/kg/day of Cyclosorus terminans extract (I‐200; n = 6); or 20 mg/kg/day of pioglitazone (Pio; n = 6) for additional 2 weeks. At the end of experimental period, blood and brains were collected to determine metabolic and brain functions.Result: HFD‐fed rats exhibited a prediabetic condition as characterized by obesity with peripheral insulin resistance. In addition, neuroinflammation, neuronal necroptosis, microglial and astrocyte hyperactivation, and APP expression significantly increased in HFD‐induced prediabetic rats. Cyclosorus terminans extract (100 mg/kg/day) did not attenuate the metabolic disturbance and brain pathologies in HFD‐induced prediabetic rats. Interestingly, 200 mg/kg/day of Cyclosorus terminans extract and pioglitazone equally attenuated peripheral insulin resistance, neuroinflammation, neuronal necroptosis, microglial and astrocyte hyperactivation, and APP expression in HFD‐induced prediabetic rats (P < 0.05, Figure 1).Conclusion: These findings suggest that Cyclosorus terminans extract may be another therapeutic approach for improving metabolic and brain functions in prediabetic patients who have contraindications to pioglitazone therapy.